OTC PINK : WUHN
On December 30, 2020, M2Bio Sciences announced a private placement of $ 450,000.00 USD from ThreeD Capital Inc. In these interviews with Jeff Robinson, CEO of M2Bio Sciences, and Sheldon Inwentash, CEO of ThreeD Capital Inc, explains their point of view on their partnerships and where that can bring.
According to Sheldon, this year will be the year of M2Bio Sciences. He explains that before investing, they did their research and according to them M2Bio has a more advanced science than the majority of companies in North America and have very interesting I.P.
According to Sheldon, this year will be the year of M2Bio Sciences.
For Jeff, it was more important to have a strategic partner than just having the money. We can expect announcements soon and Jeff is also talking about an upcoming strategic partner.
The future looks very bright for M2Bio Sciences, which trades on the OTC with a market value of only $15Millions.
PSYCHEDELICS MARKET VALUE
Watch video here :
Sign up for MORE news updates !
This article is written and published by The Cannabis Stock
Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies
The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.